Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Respiration; International Review of Thoracic Diseases|November 23, 2012
Efficacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fibrosisNaohiro Watanabe, Hiroyuki Taniguchi, Yasuhiro Kondoh, et al.Thoracic Cancer|January 19, 2022
Risk factors for pneumonitis in patients with non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysisTeppei Yamaguchi, Junichi Shimizu, Yuko Oya, et al.International Journal of Clinical Oncology|April 18, 2013
Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosisNaohiro Watanabe, Hiroyuki Taniguchi, Yasuhiro Kondoh, et al.Anticancer Research|March 10, 2015
Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumoniaNaohiro Watanabe, Seiji Niho, Keisuke Kirita, et al.Frontiers in Oncology|June 26, 2024
The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic reviewYutaka Fujiwara, Kazuhiro Shimomura, Teppei Yamaguchi, et al.Journal of Thoracic Disease|June 17, 2024
Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung diseaseTeppei Yamaguchi, Junichi Shimizu, Fumie Shigematsu, et al.Bioscience Trends|January 16, 2018
The response of common marmoset immunity against cedar pollen extractYoshie Kametani, Yuko Yamada, Shuji Takabayashi, et al.Blood|April 6, 2007
Basophils are essential initiators of a novel type of chronic allergic inflammationKazushige Obata, Kaori Mukai, Yusuke Tsujimura, et al.Japanese Journal of Clinical Oncology|April 4, 2015
Docetaxel for platinum-refractory advanced thymic carcinomaNaohiro Watanabe, Shigeki Umemura, Seiji Niho, et al.Case Reports in Oncology|October 30, 2024
Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case ReportYutaka Fujiwara, Katsuhiro Masago, Reiko Matsuzawa, et al.Pageof 7